Brief: Aerovate Therapeutics - Exchange Ratio Assumes Valuation For Aerovate Of $8.0 Million And Valuation For Jade Of $175.0 Million

Jade Biosciences

31/10/2024 13:55

Oct 31 (Reuters) - Aerovate Therapeutics Inc  AVTE.O :
    * AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES  VALUATION
FOR
AEROVATE OF $8.0 MILLION AND  VALUATION FOR JADE OF $175.0
MILLION
    * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER
SPECIFIED
CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF
$2.3 MILLION
    * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER
CERTAIN
CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF
$5.3 MILLION

Source text:  ID:n0001104659-24-112896 
Further company coverage:  AVTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))